To include your compound in the COVID-19 Resource Center, submit it here.

SCLN starts Phase II Zadaxin trial in melanoma

SciClone (SCLN) initiated a 20 patient Phase II

Read the full 84 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE